High Free Cash Flow Stocks
BIM.PA is currently part of our High Free Cash Flow Stocks screen, indicating it generates strong cash flows relative to its price.
BIOMERIEUX (BIM.PA) Stock Price & Overview
EPA:BIM • FR0013280286
Current stock price
71.7 EUR
+3.45 (+5.05%)
Last:
The current stock price of BIM.PA is 71.7 EUR. Today BIM.PA is up by 5.05%. In the past month the price decreased by -21.9%. In the past year, price decreased by -39.54%.
BIM.PA Key Statistics
52-Week Range68.05 - 128.3
Current BIM.PA stock price positioned within its 52-week range.
1-Month Range68.05 - 94.65
Current BIM.PA stock price positioned within its 1-month range.
- Market Cap
- 8.486B
- P/E
- 19.64
- Fwd P/E
- 14.88
- EPS (TTM)
- 3.65
- Dividend Yield
- 1.34%
BIM.PA Stock Performance
Today
+5.05%
1 Week
-2.12%
1 Month
-21.90%
3 Months
-26.69%
Longer-term
6 Months -35.75%
1 Year -39.54%
2 Years -28.30%
3 Years -24.45%
5 Years -27.52%
10 Years +91.14%
BIM.PA Stock Chart
BIM.PA Stock Screens
BIM.PA currently appears in the following ChartMill screener lists.
Value Stocks with Strong Balance Sheets
BIM.PA is currently part of our value stocks with Strong Balance Sheets screen, indicating it cheap while meeting strict financial health and debt criteria.
Dividend Growth Stocks
BIM.PA is part of our Dividend Growth Stocks screen, indicating it has a reliable dividend with grows strongly
RSI Oversold Stocks
BIM.PA is flagged as RSI oversold, meaning recent selling pressure has pushed momentum to extreme levels that may lead to a short-term rebound.
BIM.PA Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to BIM.PA. When comparing the yearly performance of all stocks, BIM.PA is a bad performer in the overall market: 95.73% of all stocks are doing better.
Chartmill TA Rating
Chartmill Setup Rating
BIM.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to BIM.PA. BIM.PA is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
BIM.PA Earnings
On April 23, 2026 BIM.PA reported an EPS of 2.3 and a revenue of 2.03B. The company beat EPS expectations (10.55% surprise) and missed revenue expectations (-2.83% surprise).
Next Earnings DateJul 28, 2026
Last Earnings DateApr 23, 2026
PeriodQ4 / 2025
EPS Reported€2.30
Revenue Reported2.026B
EPS Surprise 10.55%
Revenue Surprise -2.83%
BIM.PA Forecast & Estimates
17 analysts have analysed BIM.PA and the average price target is 117.49 EUR. This implies a price increase of 63.86% is expected in the next year compared to the current price of 71.7.
For the next year, analysts expect an EPS growth of 32.05% and a revenue growth 2.93% for BIM.PA
Analysts
Analysts74.12
Price Target117.49 (63.86%)
EPS Next Y32.05%
Revenue Next Year2.93%
BIM.PA Index Membership
BIM.PA is currently included in the following stock indexes tracked on ChartMill.
BIM.PA Financial Highlights
Over the last trailing twelve months BIM.PA reported a non-GAAP Earnings per Share(EPS) of 3.65. The EPS decreased by -5.44% compared to the year before.
Income Statements
Revenue(TTM)4.07B
Net Income(TTM)397.50M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 9.77% | ||
| ROA | 7.13% | ||
| ROE | 9.69% | ||
| Debt/Equity | 0.08 |
Chartmill High Growth Momentum
EPS Q2Q%12.75%
Sales Q2Q%-2.5%
EPS 1Y (TTM)-5.44%
Revenue 1Y (TTM)2.26%
BIM.PA Ownership
Ownership
Inst Owners18.63%
Shares118.36M
Float39.32M
Ins Owners0.05%
Short Float %N/A
Short RatioN/A
BIM.PA Industry Overview
BIM.PA operates in the Health Care Equipment sub-industry within the Health Care sector. This group contains 35 stocks and is scored by ChartMill on both price strength and growth momentum.
Industry Strength Score
39/100
Composite price performance score based on 3, 6, and 12-month returns, with more weight on recent trends.
Industry Growth Score
70/100
Composite growth score based on earnings growth, revenue growth, and profitability across the sub-industry.
Relative Performance
Each rank shows how many other sub-industries were outperformed over that timeframe.
1 Month Rank
34%
Outperformed 34% of sub-industries
3 Month Rank
30%
Outperformed 30% of sub-industries
6 Month Rank
32%
Outperformed 32% of sub-industries
Industry Fundamentals & Breadth
- Members
- 35
- New Highs
- 2.9%
- New Lows
- 11.4%
- Average ROE
- 9.8%
- Average Profit Margin
- 9.9%
- Average Operating Margin
- 14.8%
- Average P/E
- 15.7
- Average Fwd P/E
- 13.7
- Average Debt/Equity
- 0.6
BIM.PA Competitors/Peers
The largest stocks on the EU markets in the "Health Care Equipment" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 2M6 | MEDTRONIC PLC | 13.05 | 87.766B | ||
| SHL | SIEMENS HEALTHINEERS AG | 13.17 | 39.345B | ||
| PHIA | KONINKLIJKE PHILIPS NV | 14.77 | 21.56B | ||
| PHI1 | KONINKLIJKE PHILIPS NV | 14.76 | 21.55B | ||
| OBCK | OTTOBOCK SE & CO KGAA | 19.4 | 3.731B | ||
| DIA | DIASORIN SPA | 14.33 | 3.246B | ||
| AFX | CARL ZEISS MEDITEC AG - BR | 14.14 | 2.368B | ||
| DRW3 | DRAEGERWERK AG - PREF | 11.01 | 1.679B | ||
| DRW8 | DRAEGERWERK AG | 8.61 | 1.313B | ||
| ELN | EL.EN. SPA | 17.32 | 1.052B | ||
| EUZ | ECKERT & ZIEGLER SE | 18.95 | 969.315M | ||
| GVS | GVS SPA | 16.11 | 800.231M |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Paris Exchange | Find stocks with similar TA and Setup ratings on the EuroNext exchanges | Find stocks with similar Fundamental rating on the EuroNext exchanges | Find the competitors with the best technical ratings on the EuroNext exchanges | Find the competitors with the best fundamentals on the EuroNext exchanges | Find the competitors with the best valuation on the EuroNext exchanges | Find the competitors with the best dividend on the EuroNext exchanges | Find the competitors with the best analyst ratings on the EuroNext exchanges
About BIM.PA
Company Profile
bioMérieux SA engages in the provision of in vitro diagnostic solutions, which determine the source of disease and contamination. The company is headquartered in Craponne, Auvergne-Rhone-Alpes and currently employs 15,226 full-time employees. The company went IPO on 2004-06-07. The firm designs, develops, manufactures and sells systems used in clinical applications, such as for the diagnosis of tuberculosis, respiratory infections, among others and industrial applications, such as for the analysis of industrial or environmental samples. The firm also provides its customers with related services for the installation and maintenance of instruments, and training for product users. BioMerieux SA operates through its numerous subsidiaries in various countires, including bioMerieux Deutschland GmbH, bioMerieux Austria GmbH, Advencis, bioMerieux Benelux SA/NV, as well as BioFire Diagnostics Inc., chromID CARBA SMART and new bi-plate Petri dish.
Company Info
IPO: 2004-06-07
BIOMERIEUX
376, chemin de l'Orme
Craponne AUVERGNE-RHONE-ALPES FR
Employees: 14894
Phone: 33478872000
BIOMERIEUX / BIM.PA FAQ
What does BIOMERIEUX do?
bioMérieux SA engages in the provision of in vitro diagnostic solutions, which determine the source of disease and contamination. The company is headquartered in Craponne, Auvergne-Rhone-Alpes and currently employs 15,226 full-time employees. The company went IPO on 2004-06-07. The firm designs, develops, manufactures and sells systems used in clinical applications, such as for the diagnosis of tuberculosis, respiratory infections, among others and industrial applications, such as for the analysis of industrial or environmental samples. The firm also provides its customers with related services for the installation and maintenance of instruments, and training for product users. BioMerieux SA operates through its numerous subsidiaries in various countires, including bioMerieux Deutschland GmbH, bioMerieux Austria GmbH, Advencis, bioMerieux Benelux SA/NV, as well as BioFire Diagnostics Inc., chromID CARBA SMART and new bi-plate Petri dish.
What is the stock price of BIOMERIEUX today?
The current stock price of BIM.PA is 71.7 EUR. The price increased by 5.05% in the last trading session.
What is the dividend status of BIOMERIEUX?
BIOMERIEUX (BIM.PA) has a dividend yield of 1.34%. The yearly dividend amount is currently 0.9.
What is the ChartMill rating of BIOMERIEUX stock?
BIM.PA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
How is the valuation of BIOMERIEUX (BIM.PA) based on its PE ratio?
The PE ratio for BIOMERIEUX (BIM.PA) is 19.64. This is based on the reported non-GAAP earnings per share of 3.65 and the current share price of 71.7 EUR.
Would investing in BIOMERIEUX be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on BIM.PA.
Can you provide the number of employees for BIOMERIEUX?
BIOMERIEUX (BIM.PA) currently has 14894 employees.